A microfluidic device was developed and employed for preclinical assessment of the toxicity of engineered T cells towards tumour cell aggregates embedded in a 3D matrix.51 The device was designed for the evaluation of T cell function against single tumour cells and aggregates depending on addition of interferon gamma and TNFα. This evidence concerns the gene IFNG and neoplasm.